JonasVan den Bossche

Partner

Brussels + 32.2.645.14.12

Connect:

Share

Jonas Van den Bossche has more than 12 years of extensive experience in complex domestic and cross-border M&A deals, joint ventures, and real estate. He also advises clients on general civil, commercial, corporate governance, and corporate law issues. Jonas has been with Jones Day since 2008 and also spent 18 months in the Firm's London Office, where he has advised on cross-border M&A, capital markets, and private equity transactions.

Recent representative transactions include Suez' €1.1 billion divestiture of its recycling and recovery operations in four European countries to PreZero, Arsenal Capital's acquisition of HistoGeneX, HRH Prince Abdullah's acquisition of Belgian football club Beerschot, and Hansteen's sale of its entire Belgian real estate portfolio.

Other major companies Jonas has advised include Astellas, Barco, Bridgestone, Diebold, Ferrostaal, Global City Holdings N.V., Heidrick & Struggles, Hexagon, International Automotive Components Group, Macquarie Bank, MasterCard, Mitsui Chemicals, Pioneer, Procter & Gamble, Solvay, Starwood Corporation, Toyota Motor Corporation, Wabtec Corporation, and Van Hool.

Experience

  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Solvay sells barium, strontium and sodium percarbonate businesses to Latour CapitalJones Day advised Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, on the combined sale of its technical-grade barium and strontium business in Germany, Spain and Mexico, and its sodium percarbonate business in Germany to Latour Capital.
  • Furukawa Electric and Superior Essex global joint venture finalizedJones Day advised Furukawa Electric Co., Ltd. in its finalization of a global joint venture with Superior Essex Inc.
  • Beerschot arbitrates various decisions taken following termination of football competition in light of COVID-19 crisisJones Day successfully represented KFCO Beerschot-Wilrijk NV, a Belgian football club in multiple arbitration proceedings before the Belgian Arbitration Tribunal for Sports against the Royal Belgian Football Association and the Pro League in relation to decisions taken following the termination of the Belgian football competition in light of the COVID-19 crisis, thereby facilitating its promotion to competition 1A.
  • Advanced medical products manufacturer weighs labor and employment approach to international multijurisdictional mattersJones Day is providing multijurisdictional advice on all aspects of labor and employment law to an advanced medical products manufacturer in several labor and corporate law matters, including hirings, terminations, possible litigation with independent contractors, squeeze out procedures, and specific trade law matters in the Middle East and Russia.
  • De Neef family sold majority stake in De Neef Chemical Processing NV to Soudal group (Swerts family)Jones Day represented the De Neef family in its sale of a majority stake in De Neef Chemical Processing NV to the Soudal group (Swerts family).
  • Hansteen sells Belgian portfolio to Belgian real estate investorJones Day assisted Hansteen Holdings PLC in the sale of its Belgian real estate portfolio to a Belgian real estate investor.
  • Arsenal Capital Partners acquires HistoGeneX and Caprion BiosciencesJones Day advised Arsenal Capital Partners on major investments in HistoGeneX and Caprion Biosciences and the subsequent combination of the two businesses.
  • BLACKB sells Darts-ip to Clarivate AnalyticsJones Day represented the various shareholders of BLACKB in the sale of all their shares to the Belgian subsidiary of the U.S. listed company Clarivate Analytics (US) LLC.
  • HRH Prince Abdullah and DCA NV take over Belgian Proximus League Football Club Beerschot-WilrijkJones Day advised HRH Prince Abdullah bin Mosa'ad bin Abdulaziz Al Saud in his joint investment with Belgian construction company DCA NV in the Belgian Proximus League Football Club Beerschot-Wilrijk.
  • Gimv invests in Coolworld RentalsJones Day advised Gimv in its acquisition of a majority shareholding in fast-growing Coolworld Rentals, a full-service renter of cooling and heating equipment.
  • Bridgestone sells Mecamold to New Mold InternationalJones Day represented Bridgestone Europe in connection with its sale of Mecamold S.A., a Herstal, Belgium-based tire mold manufacturer, to New Mold International SAS.
  • Sterigenics International acquires Toxikon Europe NVJones Day represented Sterigenics International LLC, the world’s leading, fully integrated protector of global health, in connection with its acquisition of Belgian-based Toxikon Europe NV, the European subsidiary of Toxikon Corporation, a Bedford, Massachusetts-based preclinical contract research organization.
  • Hexagon acquires Luciad from GIMVJones Day represented Hexagon AB, a global provider of information technologies that drives productivity and quality across geospatial and industrial enterprise applications, in connection with its acquisition of Belgian-based Luciad, a leading provider of 5D visualization and analysis solutions, from GIMV.
  • Astellas Pharma acquires Ogeda SA for €800 million (US$852 million)Jones Day advised Astellas Pharma Inc., a Japanese leader in the pharma industry, in its €800 million (US$852 million) acquisition of Ogeda SA, a privately owned Belgian drug discovery company.
  • Ferro acquires Cappelle PigmentsJones Day advised Ferro Corporation in connection with the acquisition of all the shares of Belgium-based Cappelle Pigments NV.
  • Suez SA sells SUEZ Finland waste management operations to Hartwall CapitalJones Day advised Suez SA in its sale of all shares in its Finnish recycling subsidiary SUEZ Suomi Oy to Hartwall Capital Oy AB.
  • Barco sells Defense & Aerospace division to U.S.-based Esterline Corporation for €150 million (US$175 million)Jones Day advised Barco NV in the sale of its Defense & Aerospace division to U.S.-based Esterline Corporation for €150 million (US$175 million).
  • Société Générale sells its majority stakes in Societe Generale Expressbank AD and Sogelife Bulgaria IJSC to OTP BankJones Day advised Société Générale in its sale of its majority stakes in Societe Generale Expressbank AD and Sogelife Bulgaria IJSC to OTP Bank.
  • Arsenal Capital Partners acquires Seal for Life Industries from Berry Global Group Inc. for $328 millionJones Day advised Arsenal Capital Partners on the $328 million acquisition of Seal for Life Industries from Berry Global Group Inc.
    • View All

    December 2020 Commentaries

    European Government Support Schemes: Current State of Play

    June 2020 White Paper

    Financial Government Support Measures Related to COVID-19 for European Corporates

    March 2019 Commentaries

    Belgium Enacts Historic Corporate Law Reform

    Additional Publications

    • December 2020
      Shareholders’ Agreements following the introduction of the New Belgian Companies and Associations Code (DAOR 2020/4)

    Speaking Engagements

    • January 15, 2019
      ELSA Maastricht lecture on "Introduction to Mergers & Acquisitions in Practice - A Perspective of Law and Business"
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.